These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 22653743)

  • 1. Discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the 'self (stem cell)-seeding' nature of breast cancer disease?
    Lopez-Bonet E; Menendez JA
    Ann Oncol; 2010 Apr; 21(4):901-902. PubMed ID: 20032125
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the 'self (stem cell)-seeding' nature of breast cancer disease?
    Faratian D; Aitken SJ; Thomas JS; Langdon SP; Harrison DJ
    Ann Oncol; 2010 Jun; 21(6):1375. PubMed ID: 20215137
    [No Abstract]   [Full Text] [Related]  

  • 3. Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma?
    Dizdar O; Aksoy S; Altundag K
    Ann Oncol; 2009 Jan; 20(1):189; author reply 189-90. PubMed ID: 18820244
    [No Abstract]   [Full Text] [Related]  

  • 4. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions.
    Lew M; Pang JC; Jing X; Fields KL; Roh MH
    Cancer Cytopathol; 2015 Oct; 123(10):576-81. PubMed ID: 26465236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic Subgroups or Individual Biomarkers for Predicting Outcome of Metastatic Breast Cancer?
    Dowsett M
    JAMA Oncol; 2016 Oct; 2(10):1269-1271. PubMed ID: 27281312
    [No Abstract]   [Full Text] [Related]  

  • 6. Understanding the age dependency of breast cancer biomarkers.
    Benz CC; Thor AD; Eppenberger-Castori S; Eppenberger U; Moore D
    Adv Gerontol; 2003; 11():117-20. PubMed ID: 12820531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of the pre-metastatic niche on breast cancer metastasis.
    Ursini-Siegel J; Siegel PM
    Cancer Lett; 2016 Sep; 380(1):281-8. PubMed ID: 26577808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of cancer self-seeding.
    Comen E; Norton L; Massagué J
    Nat Rev Clin Oncol; 2011 Jun; 8(6):369-77. PubMed ID: 21522121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer survival and immunohistochemical similarities between primary and metastatic sites, as a surrogate marker for the cancer self-seeding.
    Kurbel S; Dmitrovic B; Tomas I; Kristek J; Bozac M
    Int J Biol Markers; 2012 Jul; 27(2):e167-8. PubMed ID: 22653743
    [No Abstract]   [Full Text] [Related]  

  • 10. The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.
    Sangoi AR; Shrestha B; Yang G; Mego O; Beck AH
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):229-37. PubMed ID: 25906123
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.